Nov 21, 2019 - The FDA accepts Endo's (ENDP) BLA for CCH for the treatment of cellulite in the buttocks.
Nov 20, 2019 - Thanks to its debt offering, a heavily dilutive equity issuance has become very unlikely.The upsized offering also highlights that debt markets are not seeing a large bankruptcy risk.The only remainin
Nov 20, 2019 -
Nov 19, 2019 - Teva, Bausch Could Be Next to File for Bankruptcy, Stocks: AKAOQ,PTXTQ,TEVA,BHC,ENDP,AMRX,AKRX,AMAG,CLVS, release date:Nov 19, 2019
Nov 19, 2019 -
Nov 12, 2019 - Investors responded favorably to Teva's third-quarter earnings report.Litigation risks dissipating.Strong pipeline, initial sales of new drugs, and more.
Nov 12, 2019 -
It’s been a rough 2019 for some biotechs. Amneal Pharmaceuticals Inc (NYSE: AMRX) is down 81% year-to-date, while Teva Pharmaceutical Industries Ltd (NYSE: TEVA) is down 41%.
Nov 11, 2019 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Nov 08, 2019 - Aimed at rolling over three series of outstanding debt due in 2021, Teva Pharmaceutical Industries (TEVA +4.5%) launches a $1.5B private offering Euro-denominated Senior Notes.Pricing and terms have y
Nov 08, 2019 - Teva Pharmaceutical (TEVA) misses earnings estimate but beats the same for sales. The company increases the lower end of its 2019 sales and earnings guidance. Shares rise.